Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.

导出 LinkOut

翻译打印收藏纠错

作者： Marina O,Golovastova ^[1] ; Dmitry O,Korolev ^[2] ; Larisa V,Tsoy ^[3] ; Vladimir A,Varshavsky ^[3] ; Wan-Hai,Xu ^[4] ; Andrey Z,Vinarov ^[2] ; Evgeni Yu,Zernii ^[1] ; Pavel P,Philippov ^[1] ; Andrey A,Zamyatnin ^[5]

作者单位： Department of Cell Signaling, Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991, Moscow, Russia. ^[1] Institute of Uronephrology and Human Reproductive Health, Sechenov First Moscow State Medical University, 119991, Moscow, Russia. ^[2] Anatomic Pathology Department, Sechenov First Moscow State Medical University, 119991, Moscow, Russia. ^[3] Department of Urology, The Fourth Hospital of Harbin Medical University, Harbin, China. ^[4] Department of Cell Signaling, Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991, Moscow, Russia. zamyat@belozersky.msu.ru. ^[5] Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991, Moscow, Russia. zamyat@belozersky.msu.ru. ^[6]

关键词 Cancer-retina antigens DNA methylation Epigenetic regulations Markers Recoverin Renal cancer